Skip to content
About ViraxImmune
TM
Products
Services
Leadership
Media
Contact Us
Investor Relations
Menu
About ViraxImmune
TM
Products
Services
Leadership
Media
Contact Us
Investor Relations
EVALUATING T-CELL DRIVEN IMMUNITY IN POST-VIRAL SYNDROMES
June 13 2024
Presentation by Dr. Nigel McCracken (COO)